ArticleLife science alliance2026
Investigating the role of CpG islands and DNA methylation at 3'UTRs in cancer.
Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA methylation is one of the most important epigenetic processes that regulates gene expression. Although the human genome is predominantly methylated, CpG-rich regions known as CpG islands (CGIs) are typically unmethylated and are often sites of transcriptional control. Although the importance of CGIs and DNA methylation at the promoters is well understood, the significance of CGIs at the 3' ends remains largely unexplored. In this study, we characterised CGIs overlapping 3' untranslated regions (3'UTRs), compared them with CGIs located at the promoters, and examined their association with gene expression in cancer. We found that 3% of CGIs overlap 3'UTRs and have no annotated promoters in the vicinity. Unlike promoter CGIs, 3'UTR CGIs are shorter, less CpG-dense, but evolutionarily conserved. Although promoter CGIs typically stay unmethylated, those in 3'UTRs are often methylated and enriched for transcription factors like ZFP57, which target methylated motifs. These regions are linked to cancer signalling pathways, and their differential methylation in tumours correlates with gene expression changes, suggesting an underexplored regulatory role in cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.